1.1.3 Pharmaceutical Industry: Intellectual Property

Almost any new medical technology for consideration by an investor will insist on safety and efficacy approval by a government regulator like the United States FDA. Furthermore they will insist on an assessment of whether the intellectual property (IP) that the innovation operates in is not conflicting with other IP claims. For this milestone you will complete a brief assessment of how the innovation would be classified by the US FDA as well as generate a very cursory patent search for conflicting IP claims using common and free tools on the Internet such as Google patent search and the US Patent and Trademark office web site. The assessment should be 2-3 to pages in length.

Acerca de Coursera

Cursos, programas especializados y títulos en línea impartidos por los principales instructores de las mejores universidades e instituciones educativas del mundo.

Join a community of 40 million learners from around the world
Earn a skill-based course certificate to apply your knowledge
Gain confidence in your skills and further your career